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Abstract
Background: Non-invasive screening for atherosclerosis or
asymptomatic cardiovascular disease of the coronary and carotid
arteries is commonly undertaken, and research has been focussed on
how results from these screenings lead to behaviour change.
However, no review has focused on the effects of these results on
psychological distress and health-related quality of life (HRQoL). This
protocol will outline how a scoping review will be conducted to map all
available evidence on psychological distress and/or HRQoL outcomes
following the provision of vascular imaging results of the coronary
and carotid arteries.
Methods: Arksey and O’Malley’s (2005) framework subsequently
enhanced by Levac et al. (2010) and Peters et al (2015, 2017) will
guide the scoping review. Databases such as MEDLINE (Clarivate), APA
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PsychINFO, EMBASE, Social Work Abstracts, Psychology and
Behavioural Sciences Collection, and Cumulative Index to Nursing and
Allied Health Literature (CINAHL) will be searched using MeSH terms
such as "Coronary stenosis", "Carotid Stenosis", "Psychological
Distress" and "Quality of Life" and related terms. Two investigators will
screen title and abstract and all articles meeting inclusion criteria will
be extracted. Data on authors, publication year, country of origin,
aims/purpose, methodology, intervention, outcome measures as well
as key findings that relate to the scoping review questions will be
extracted for each included study. The findings will be presented
using tables and thematic narrative synthesis. The scoping review will
not produce a pooled estimate of the impact of vascular imaging
results on psychological distress and HRQoL but will present
information from the included studies related to psychological
distress and HRQoL.
Conclusion: The review will highlight and address gaps in knowledge
and provide direction for future investigations.
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REVISED

Amendments from Version 2

There will be no critical appraisal and risk of bias assessment
for this review and therefore the quality appraisal section in the
protocol has been removed.
Any further responses from the reviewers can be found at
the end of the article

Introduction

Cardiovascular disease (CVD) refers to diseases of the blood
vessels, and in particular the heart, brain and peripheral vasculature1. CVDs due to atherosclerosis include cerebrovascular events such as stroke, ischaemic heart disease events such
as heart attacks, and peripheral arterial diseases causing peripheral claudication1. CVD is the leading cause of death and disability globally1,2 with an estimated 17.9 million people dying
from CVDs in 2016, representing 31% of all global deaths.
Of these CVD-related deaths, 85% were due to heart attack
and stroke or their sequelae2. By 2030, it is estimated that
more than 22.2 million people will die annually from CVDs3.
Atherosclerosis before clinical events, or “asymptomatic CVD”,
can be easily visualised using a range of imaging methods, with
the most common being computed tomography of the coronary arteries to calculate coronary artery calcification (CAC) or
carotid ultrasound to identify carotid plaques and assess intimal
medial thickness4. Imaging of the arteries to identify asymptomatic CVD is becoming commonplace in medical practice5,
and provides asymptomatic individuals with a visible and tangible illustration of an otherwise hidden disease process, even
before distinctive symptoms appear6. Such information can
improve an individual’s knowledge of the disease which may
enable them to increase control over, and improve their health7.
Increased knowledge may also lead to personal and social
benefits, such as enabling effective community action and
contributing to developing one’s social capital8,9. However, diagnostic information or results related to a disease (depending
on how the situation is evaluated) may also affect an individual’s sense of well-being10 or lead to psychological distress6,11,12.
For example, previous studies have reported that women
who undergo mammography screening may be susceptible to
psychological distress following the provision of results13–21.
Psychological distress, often referred to as mental distress,
refers to the unique discomforting emotional state an individual experiences in response to a particular demand or stressor
that causes temporary or permanent harm to them22. Psychological distress often manifests through attributes including:
(a) discomfort (e.g., anguish, misery, suffering); (b) perceived
inability to effectively cope (e.g., inability to solve problems);
(c) communication of discomfort (e.g. facial expressions);
(d) loss of independence and confidence (e.g. dependency,
decreased self-esteem);and/or (e) changes in emotional status
(e.g. change from stable emotional state to one of depression,
self-depreciation, amotivation, dysregulated motivation or maladaptive motivation, aggressiveness, irritability, nervousness,

and anxiety)23–33. Quality of Life (QOL) encompasses a person’s
psychological state, appraisals of physical health, personal beliefs
as well as social relationships34. It is often measured in research
using physical and mental health summary scores35. This review
focuses on health-related quality of life (HRQoL), which refers
to a multidimensional construct encompassing appraisals of
physical and emotional health, wellness or illness36–38. HRQoL
is generally considered as the most suitable variant of quality of life when one is investigating medical conditions or
disease related outcomes39. HRQoL and psychological distress
have been extensively studied in health research40–46. Reported
impaired HRQoL (e.g., illness , role limitations due to physical
or emotional/psychological problems), improved HRQoL (e.g.,
wellness, improved physical or mental health) and psychological
distress (e.g., anxiety, depression, worry) following screening
are the outcomes of interest for this scoping review.
Psychological outcomes will be reported under HRQoL
domain in this scoping review if they were categorised as
QoL/HRQoL in the included studies (e.g., measured using
validated QoL/HRQoL instrument and reported as impaired/
improved QoL/HRQoL). Psychological outcomes will also be
reported under psychological distress domain in this scoping
review if they were measured and reported as a single psychosocial
variable (e.g., depression, self-esteem, anxiety).
The scoping review was informed by Witte’s47 extended
parallel process model (EPPM) and cognitive stress appraisal
theory48. Based on the constructs of the EPPM47, the provision
of information—in particular, negative information—about a
person’s coronary artery calcium and carotid plaque (and the
potential implications of this condition) is likely to stimulate
subjective ‘threat’ appraisals (i.e., perceived susceptibility to,
and severity of, CVD)49. Depending on interactions between
that threat appraisal and individuals’ efficacy appraisals, individuals may react to screening information by (a) adopting
danger control responses (including attitudes, beliefs, behavioural intentions, and/or behaviours) that align with message
recommendations, or (b) adopting fear control processes
(such as denial, reactance, and avoidance) intended to reduce
fear rather than take protective action50. Behavioural intentions and/or behaviours such as increasing physical activity,
health responsibility, good nutrition, and stress management
could impact health outcomes51. Behavioural intentions and/or
behaviours are also associated with lifestyle related disease
burden such as CVD52 which could undermine HRQoL53.
Cognitive stress appraisal theory48 also proposes that individuals
primarily evaluate circumstances/situations as ‘challenging’
(i.e., threat that can be overcome or met) or ‘threatening’
(i.e., anticipated loss/harm)48. Positive cognitive stress appraisal
(i.e. appraising a situation as a challenge to be resolved and
setting goals to achieve that) may contribute to prevention of
depression and improved HRQoL54. Negative appraisals of
stress—viewing an issue such as detected atherosclerotic plaque
in the arteries as a threat and believing that resolving it is beyond
one’s abilities—may, however, lead to psychological distress55–57.
Based on the EPPM and cognitive stress appraisal frameworks, we therefore hypothesized that; (a) population screening
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to detect atherosclerotic plaque in the coronary or carotid arteries can influence HRQoL, and (b) population screening to
detect atherosclerotic plaque in the coronary or carotid arteries
can cause psychological distress. To date, however, the available evidence that may support (or refute) these hypotheses
has not been scrutinised or reported in any coherent manner.
Hence, there is a need for a scoping review to synthesize the
state of scientific literature on this subject.
Scoping reviews aim to map key concepts, main sources and
types of evidence available in a research area and can be
undertaken where an area is complex or has not been
comprehensively reviewed before58. Previous reviews reported
very little evidence relating to HRQoL or psychological
distress following provision of vascular imaging results to
asymptomatic adults7,59–62. It is important, therefore, to collate
evidence relating to the findings available in this field, how
studies in this field have been conducted, the key characteristics
of studies, and important knowledge gaps. As such, this scoping
review will comprehensively map the evidence on psychological
distress and HRQoL outcomes following provision of vascular
imaging results of the coronary or carotid arteries to asymptomatic adults. We will also report other details of included
studies that we deem important in this scoping review (e.g.,
the information provided during counselling and whether the
counselling could reduce distress, or any information included
in the results that shaped the nature of the response).

Study rationale and guiding question

There is great interest (and value) in providing people with vascular imaging results of the coronary and carotid arteries to
prompt healthful behaviour change and better management of
CVD7,60. However, the provision of the imaging results may
produce markedly different emotions—and as a result, downstream behaviours—depending upon the way in which they are
received and appraised. Also, the uncertainty about a possible
future threat (due to coronary artery calcium and carotid
plaque) may cause anxiety63. There is theoretical justification to
anticipate that information aimed at prompting healthful behaviour change and better management of CVD may stimulate
negative psychosocial outcomes or psychological distress such
as anxiety or depression impairing HRQoL. Accordingly, it is
important to identify which research questions have and have
not been addressed in this area. Also, by highlighting the extent
of findings on distress and/or HRQoL, a scoping review
could support the development of strategies designed to mitigate or prevent distress during and following such screening
exercises.
The aim of this review is to map all available evidence on
psychological distress and HRQoL outcomes among participants
who were screened for atherosclerosis by non-invasive methods and provided with their own coronary or carotid artery vascular imaging results. This scoping review will address this
research question:
1. W
 hat is the state of scientific literature on psychological
distress and HRQoL related to the provision of vascular imaging results of the coronary and carotid arteries,
and what are the gaps in that literature?

Table 1 further clarifies the core elements of the questions
guiding the conduct of this scoping review.

Protocol
Methods

Study design. The framework initially developed by Arksey
and O’Malley64 and subsequently enhanced by Levac et al.65
and Peters et al.66–68 will be used for this scoping review. The
framework involves stages such as: (1) identifying, clarifying,
defining and linking the purpose of the study and the research
question; (2) identifying relevant studies, balancing comprehensiveness and breadth with feasibility; (3) developing and
aligning inclusion criteria with study questions and objectives;
(4) using an iterative approach to study selection and data
extraction; (5) using a planned approach to searching evidence,
study selection, extracting data, and evidence presentation;
(6) incorporating qualitative thematic analysis and numerical
summary to collating, summarizing and reporting the results;
and (7) Summarizing the evidence in relation to the aims of the
review, making conclusions and identifying any implications
for practice, policy or research. The reporting of this scoping
review will also be guided by the PRISMA extension for scoping
review reporting checklist69.

Identifying relevant studies
Information sources and search strategy. The main purpose
of a scoping review is to comprehensively identify primary
studies (published and unpublished) and reviews suitable for
answering the review questions. To achieve this, databases such
as MEDLINE (Clarivate), APA PsychINFO, EMBASE, Social
Work Abstracts, Psychology and Behavioural Sciences Collection, and Cumulative Index to Nursing and Allied Health
Literature (CINAHL), will be searched for articles of relevance. Further manual searching of reference lists in identified
articles will be undertaken to include other studies of relevance. We will also search relevant grey literature databases
such as Open Grey and Open Access Theses and Dissertations
(OATD) to identify relevant studies.
Approach to developing search strategy. Different sources
(e.g. MeSH headings and thesaurus) will be used to identify
terms and synonyms to comprehensively cover the research
questions as much as possible70–73. The proposed search strategy was developed in consultation with an academic librarian
(Table 2) for MEDLINE using MeSH terms such as “Coronary
stenosis”, “Carotid Stenosis”, “Psychological Distress” and
“Quality of Life”. We also used Boolean operators “AND”
to narrow search results to include only relevant results containing required keywords and “OR” to expand search results
and combine synonyms. Other keywords such as behaviour,
lifestyle, motivation, risk perception, medication adherence and
smoking cessation were included to capture all relevant studies as mental health and HRQoL outcomes are unlikely to be
primary or secondary outcomes and thus reported in the title
or abstract. This search strategy will be modified for use in
other databases. Due to the exploratory nature of scoping
reviews and the need to ensure a comprehensive search of relevant literature, an iterative approach to search strategies will
be employed64. This implies that the search strategy will be
Page 4 of 16

F1000Research 2021, 9:1376 Last updated: 23 FEB 2022

Table 1. An overview of core elements of scoping review questions. HRQoL, health-related quality of life
CORE ELEMENTS

EXPLANATION

SCOPE OF THE
REVIEW

Global

SETTING

Community and/or clinical settings

POPULATION

Adult participants who have been screened for coronary artery calcium/calcification or carotid plaque/
stenosis

INTERVENTION

Screening for atherosclerosis in the coronary or carotid arteries using non-invasive imaging techniques

COMPARISON

1. Reported psychological distress and/or HRQoL in sub-groups provided with results of detected
atherosclerotic plaque after screening and those without
2. Reported psychological distress and/or HRQoL in sub-groups within different risk categories (e.g. no
risk/normal, low risk, mild risk, moderate risk and high risk groups)
3. Reported psychological distress and/or HRQoL in sub-groups with knowledge of test results and those
without
4. Reported psychological distress and/or HRQoL in sub-groups screened and provided results and nonscreening group
5. Reported psychological distress and/or HRQoL in populations before and after provision of results

EVALUATION

Reported changes/no changes or differences/no differences in psychological distress and/or HRQoL
following the provision of vascular imaging results of an individual’s carotid or coronary arteries; how
studies were conducted and important knowledge gaps.

Table 2. Proposed search strategy. MeSH, Medical Subject Headings; CAC, Coronary Artery Calcium.
“coronary stenosis”[MeSH Terms] OR Coronary Stenosis [Text Word] OR Coronary artery stenosis OR “Carotid Stenosis”[MeSH]
OR Carotid plaques OR Carotid ultrasound OR Coronary artery calc* OR Coronary calc* OR CAC score* OR Coronary artery
calcium score OR Calcium score
AND
Mental* OR “Psychological Distress”[MeSH] OR Psych* OR “Quality of Life”[MeSH] OR “Anxiety”[MeSH] OR Anx* OR
“Depression”[MeSH] OR Dep* OR mood OR Worr* OR alarm OR Lifestyle change OR Behaviour change OR Behaviour OR
Lifestyle OR Motivation OR Risk perception OR Risk perception* OR Medication adherence OR smoking cessation

updated as we discover new terms as we work through the
review.
These terms will be searched as keywords in the title and
abstract headings and no date limits will be applied. Search
results will be downloaded, imported and saved as Microsoft
Word and PDF documents. Database outputs will be compared
to check for the existence of any duplicates.

Study selection
Databases and records will be screened using the eligibility
criteria (see below) and studies not meeting the criteria will
be excluded. The process for identification, screening, eligibility and studies to be included is displayed in Figure 1.
The process of searching and selection will be reported in the
main review using a PRISMA flowchart74.
The screening will begin with title and abstract screening by
two investigators (RA and JRL) who will independently screen

the titles and abstracts for all retrieved records for inclusion
and to agree on exclusions. This process will be piloted using a
sample of abstracts to ensure that this approach will be efficient enough to capture all relevant articles. Any articles that
meet the inclusion criteria or that cannot be excluded will be
retained for full text review. For the second stage, two investigators (RA and JRL) will each independently screen the full
text of articles to determine if they meet the inclusion criteria and conflicts will be resolved by an independent reviewer
(LCB) and data from included studies will be extracted.
Inclusion criteria
The following inclusion criteria will apply:
a) Study characteristics
Studies must be of adults who are 18 years and over and asymptomatic (not screened due to clinical symptoms such as chest
pain or angina) and without pre-existing CVD (e.g., stroke,
myocardial infarction, peripheral arterial disease or transient
Page 5 of 16
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Figure 1. Selection process chart.

ischemic attack). Studies may report follow-up assessment and
outcomes such as psychological distress and/or HRQoL after
participants received information related to their own coronary
artery calcification or carotid stenosis/plaque.
b) Study types
Study types that will be included for this scoping review are
empirical studies of any type. No year of publication and
language restrictions will be applied.
Concepts
i) Imaging results
Information regarding the state of arteries, extent of stenosis,
extent of coronary artery calcification, or carotid/atherosclerotic
plaques, coronary calcium score, arterial wall irregularities or
obstructive artery walls conveyed to study participants.
ii) Psychological distress and HRQoL
An article may report psychological distress (e.g., anxiety,
depression, impulsivity, worry, psychoticism, impulsivity, aggression, obsession-compulsion, or interpersonal sensitivity) and/or
QoL/HRQoL (i.e., an individual’s self-perceived health status)
as an outcome or include QoL/HRQoL measure using a
standard instrument to be included in this review.
c) Context
This scoping review will include studies conducted in
any geographical location among any racial/ethnic group

and gender. Studies will be included irrespective of their
settings.
Exclusion criteria
a) Study types, participants, and imaging methods
Studies in symptomatic patients undergoing invasive imaging for diagnostic purposes will be excluded. Other studies
that will be excluded are studies providing imaging results of
other vascular diseases/conditions such as Aneurysm or Endoleak;
Angiodysplasia; Angioedema; Angiomatosis (Bacillary Angiomatosis, Klippel-Trenaunay-Weber Syndrome, Sturge-Weber
Syndrome, von Hippel-Lindau Disease); Arteriovenous
Malformations; Capillary Leak Syndrome; Ischemic Colitis;
Compartment Syndromes; Diabetic Angiopathies; Hand-Arm
Vibration Syndrome; Hemorrhoids; Hemostatic Disorders;
Hyperemia; Hepatic Veno-Occlusive Disease; Hypotension;
Peliosis Hepatis; Ischemic Optic Neuropathy; Pulmonary
Veno-Occlusive Disease; Scimitar Syndrome; Retinal Vein
Occlusion;Pulmonary Vein Stenosis; Splenic Infarction; Superior Vena Cava Syndrome; Telangiectasis; Varicocele; Thoracic
Outlet Syndrome; Varicose Veins; Vascular Fistula; Vascular Neoplasms; Vascular System Injuries; Vasculitis as well as
Vasoplegia and Venous Insufficiency.
b) Outcomes
Studies without outcomes considered as psychological distress
and/or QoL/HRQoL will be excluded. We will also exclude
studies where psychological distress/psychiatric and/or QoL/
HRQoL assessments were performed only before vascular
imaging procedure and not after provision of imaging results.
Page 6 of 16
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Charting the data
A draft data extraction chart will be developed and piloted
with a selection of identified studies. The diagrammatic or
tabular form of presentation or charting will be used for this
study. The potential chart categories may consist of authors
information (names, year of publication, study location), participant characteristics (age, gender), research design, methods,
instruments/techniques/clinical assessments used to gather
data on coronary artery calcification, carotid plaque/stenosis,
psychological distress, HRQoL and aims/purpose of the
extracted studies (Table 3). We will also extract data on how
vascular imaging results were provided and whether there was
additional counselling or support mechanisms.

Study findings and dissemination
The findings from this review will be submitted to peerreviewed journals to be considered for publication and may be
presented at scientific conferences. Also, we aim to share our
results with key stakeholders to influence policy and practice.

EndNote X9 will be used as a reference management tool and
to avoid duplications. Microsoft Excel and Word will be used
to manage data within the review team.

Pilot screening of search results: Yes

Collating, summarizing and reporting the results
This review will employ thematic and numeric approaches to
summarise studies. A thematic approach will be used to summarise the main and sub-themes that will emerge after the scoping
exercise. A numeric approach will also be used to summarise
results of the scoping review by presenting the quantity of each
emerging concept (e.g., worry was used interchangeably with
anxiety (n=2) or most of the studies (n=25) measured depression using the Center for Epidemiological Studies Depression
(C-ESD) instrument). The scoping review will not produce a
pooled estimate of the impact of vascular imaging results on
psychological distress and/or HRQoL as we aim to preliminary
assess the potential size, scope and gaps in available literature.
Results on the state of scientific literature will be reported and
the gaps in the literature will be identified. There will be further discussion on the implications of the results for practice
and future research.

Study status

Start date of search: August 2020; anticipated date of completing
review: July, 2021
Current study status:
Preliminary searches: Yes
Piloting search strategy: Yes

Study selection process piloting: Yes
Formal screening of search results against eligibility criteria:
Started
Data extraction: Started
Data analysis and interpretation: Started

Conclusion

The purpose of this protocol is to describe the methodological considerations that will guide the completion of a scoping review that will summarise the extent, range and nature
of studies on psychological distress and/or HRQoL outcomes
reported among asymptomatic adults following the provision
of vascular imaging results. This comprehensive review will
help advance knowledge about potential negative effects of
screening for asymptomatic CVD to elicit healthful behaviour
changes. It could also possibly enable the development of
strategies to prevent distress. The results of this review will
help advance knowledge in this field and will be useful
for future medical practice when providing vascular imaging

Table 3. Summary of data extraction items. HRQoL, health-related quality of life.
RECORD DETAILS

Last name of first author, publication year, journal

STUDY

Study purpose

SETTING

Study location

POPULATION

Age of participants, gender of participants, sample

INTERVENTION

Imaging technique used, results provision details, follow-up period after baseline screening, psychological
distress and HRQoL outcome assessment instruments, counselling/additional support for study participants

STUDY DESIGN/
TYPE

As reported by authors or as defined by review team

OUTCOMES

Key psychological distress and/or HRQoL outcomes reported by authors
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results to patients, cardiovascular research, and future clinical trials providing vascular imaging results to participants.
This scoping review will be limited to studies reporting coronary or carotid artery plaque screening only as these are the
commonly used structural vascular imaging modalities for
large screening initiatives of asymptomatic individuals.

Ethics approval and consent to participate

There will be no formal ethical application and ethical review
as no primary data will be collected.

Data availability

No data are associated with this article.
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